Imaginatik is a Top Tip for 2009: Price @ 3.25 pence, rating 6./10 Note that CF Techinvest Funds does not have a holding in Imaginatik:
“Top tips stocks are given a Rating on a scale from 1 to 10. The Rating is not, however, a figure of merit. It merely relates to the degree of risk attached to the stock at the price shown and in the light of current known information on the Copmpany.
“The more speculative the stock, the lower the number. The least risky have high numbers. However, a 10 does not imply the price is certain to go up, no more than a 1 means it is almost sure to go down.”
techinvest-imaginatik-top-tips-for-2009-1-jan-09
Update on Imaginatik
Imaginatik (IMTK; 3.25p) was a New Buy recommendation (at 4.38p) last August, followed by several Update notes since, most recently December. Although the shares are down by 57%, nothing we can find has since changed in the fundamentals that would justify the fall.
Last month’s Update note reviewed results for the hall year to September 30. Pretax loss almost halved to £0.47m on turnover ahead by 56% to £1.80m, boosted by 10 new annual fee paying customers. Cash and equivalents amounted to £0.49m (0.4p per share). With a strong pipeline and over £1.4m of renewals revenue expected to be booked in the traditionally stronger second half, the Company’s outlook seems very promising.
Although it may not report a profit for the year, broker WH Ireland thinks it could achieve eps of at least 0.5p for the year to 31 March 2010. a prospective P/E of 6.5. Chief Executive Mark Turrell added 30.000 shares at 3p on November 14, followed by 55,000 at 1.85p on December 17. increasing his family’s stake to 59.4% (78.0 million shares). US pharma giant Pfizer, an existing customer for the Group’s Idea Central software, injected £0.5m at 6.22p for a 6.4% stake last February.
Previous Techinvest Stories in Imaginatik at Imaginatik Investor News blog
